BofA analyst Adam Ron downgraded Oscar Health (OSCR) to Underperform from Neutral with a price target of $13.50, down from $21.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.